Clinical Trial Update: Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System

View source ↗

Summary

This clinical trial update indicates that StelKast's Stelkast Surpass Acetabular System post-approval surveillance study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip

Snippet

Sponsor: StelKast, Inc. | Conditions: Survivorship and Long-term Safety and Effectiveness of the Stelkast Surpass Acetabular System | Status: TERMINATED